Concepedia

Kevin Fitzgerald

KF

Statistics

Publications

83

Citations

21.9K

H-Index

54

Active since

1988

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

Harvard University

Massachusetts Institute of Technology

Massachusetts General Hospital

Center for Systems Biology

Kevin Fitzgerald is an author at Alnylam Pharmaceuticals (United States) specializing in life sciences, molecular biology, and gene expression.

Publications per year

1988–2024

83

Publications

83

Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape

Jérôme Gilleron, William Querbes, Anja Zeigerer et al. · Nature Biotechnology · 2013 · 1.6K citations

, , +17

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

Akin Akinc, Martin A. Maier, Muthiah Manoharan et al. · Nature Nanotechnology · 2019 · 1.6K citations · Full text

, , +16

Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKCα, but Not S6K1

David A. Guertin, Deanna M. Stevens, Carson C. Thoreen et al. · Developmental Cell · 2006 · 1.4K citations · Full text

, , +10

Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based Mechanisms

Akin Akinc, William Querbes, Soma De et al. · Molecular Therapy · 2010 · 1.2K citations · Full text

, , +17

From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus

Alanna Strong, Maria Frank-Kamenetsky, Noemi E Lee et al. · Nature · 2010 · 1.2K citations · Full text

, , +10

1–5 of 83